PLoS Medicine— A Medical Journal for the Internet Age by Eisen, Michael B et al.
PLoS Medicine  |  www.plosmedicine.org 002
Open access, freely available online
October 2004  |  Volume 1  |  Issue 1  |  e31
T
he Internet is awash with 
medical information. Eight 
hundred million people have 
direct access to the Internet [1], 
and in the United States over 60% 
have searched for health or medical 
information on the Web [2]. Go to 
any search engine and type in the 
name of a disease or drug, and you 
will be directed to hundreds of sites, 
ranging from the sound and useful to 
the quackish and dangerous. Google 
“medical” and you get 85 million pages, 
“drug,” 40 million, and “health,” 230 
million. 
But something is conspicuously 
missing. The most reliable medical 
information on the Internet—the 
contents of peer-reviewed medical 
journals—is hidden from the public 
and most of the world’s physicians. 
Although most medical journals are 
available online, their publishers limit 
access to those who choose, and can 
afford, to pay for access. This should 
not, and need not, be so.
In the 19th and early 20th centuries 
independent physicians and small 
medical societies, interested in making 
the best new medical knowledge 
available to doctors, students, and 
the public, began to publish general 
medical journals containing case 
reports, ideas for new treatments, and 
the results of medical experiments. 
These pioneers took advantage of 
the best available technology for 
disseminating information, printing 
titles like The Lancet, The New England 
Journal of Medicine, and The Journal of the 
American Medical Association on cheap 
paper and selling them to subscribers 
at a few pennies a copy. For more than 
a century, printed journals like these 
were the dominant means of conveying 
medical knowledge around the world. 
But technology has changed. The 
Internet is now the most economical 
and efﬁ  cient conduit for the delivery 
of information to most places. 
Publishers of medical journals realize 
this—when the Internet took off, 
they took their journals online. But 
while they adapted their means of 
distribution to the 21st century, they 
left their business model in the 19th 
century, continuing to charge readers 
for access just as they had done for 
their printed journals. This has been 
good for business—medical publishing 
has never been more proﬁ  table—but it 
comes at a huge cost. The established 
medical publishers have turned their 
back on the opportunity to make the 
latest and best medical information 
available to anyone with an Internet 
connection. With the launch of 
PLoS Medicine, we are embracing this 
opportunity.
Everything published in PLoS 
Medicine is immediately freely available 
online throughout the world, with no 
restrictions on distribution, copying, 
printing, or legitimate use. Of course, it 
costs us money to publish this journal, 
and we must cover our expenses. But 
the fee-for-access business model that 
made perfect sense for the printed 
journal is no longer consistent with 
the mission of medical publishing 
because it needlessly limits the reach 
of the medical literature. And so we 
have adopted a new model. Instead 
of charging readers for access to our 
journal, we ask the authors of accepted 
research articles to pay a publication 
fee to cover the costs of peer review, 
editorial oversight, and production. 
This “open access” business model 
ensures our ﬁ  nancial health as a 
publisher while allowing us to convey 
everything we publish to the widest 
possible audience.
Of course, we do not expect authors 
to cover publication costs personally—
rather, we expect the government 
agencies, companies, foundations, 
research institutions, hospitals, or 
universities that sponsor the research 
to pay the fee. These organizations 
have always considered the wide 
dissemination of the results of the 
research they support to be an integral 
part of their mission. Virtually every 
leading sponsor of medical research 
has announced its willingness to pay for 
open-access publication, the costs of 
which average less than one percent of 
the cost of the research itself—a small 
price to pay to ensure that everyone 
who could beneﬁ  t from their research 
can beneﬁ  t from it. 
We realize that not everyone with 
something important to convey in a 
medical journal has access to such 
funds. To ensure that we don’t replace 
a barrier to access with barriers to 
publication, we’ve raised money to 
cover the publication costs of articles 
whose authors are unable to pay 
them. And, for every PLoS journal, 
an author’s ability to pay will never 
be a consideration in our decision to 
publish an article. 
Despite its obvious beneﬁ  ts, open-
access publication has met with ﬁ  erce 
opposition. Established medical 
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publishers—now businesses more than 
forces for change—see open-access not 
as an opportunity to fulﬁ  ll a mission of 
public service but as a threat to their 
lucrative businesses. They contend that 
their journals still serve the community 
well, and object that open access 
threatens their very existence. This is 
nonsense! 
The Wellcome Trust, the world’s 
largest charitable sponsor of 
biomedical research, seeking to ensure 
that the results of the science it funds 
are “disseminated widely and freely 
available to all,” recently commissioned 
a thorough analysis of the scientiﬁ  c 
and medical publishing industry [3]. 
It concluded that the current market 
“does not operate in the long-term 
interest of the research community,” 
and issued a strong statement in 
support of open access [4]. Responding 
to concerns about journal ﬁ  nances, 
the trust commissioned a detailed 
economic analysis of open-access 
publishing [5], based on which it 
concluded that “the open access model 
of scientiﬁ  c publishing—where the 
author of a research paper pays for 
peer reviewed research to be made 
available on the web free to all who 
wish to use it—is economically viable, 
guarantees high quality research and 
is a sustainable option which could 
revolutionise the world of traditional 
scientiﬁ  c publishing” [6]. (This report, 
freely available online, is an excellent 
resource for anyone with questions 
about the economics of open-access 
publishing).
We know ﬁ  rsthand that the 
Wellcome Trust is right. In October 
2003, we launched our ﬁ  rst journal, 
PLoS Biology, and it is thriving—not 
only as a destination for the best 
research in all areas of biology, but also 
as a resource for students, teachers, and 
members of the public who have never 
before had direct access to the product 
of scientiﬁ  c inquiry (see for yourself 
at www.plosbiology.org). We are now 
bringing this success and this spirit to 
medicine. 
The world of medical journals 
needs a fresh infusion of idealism. All 
of today’s leading medical journals 
are more than 70 years old, and PLoS 
Medicine is here to challenge the status 
quo. We are ﬁ  rst and foremost an open-
access publisher working to ensure 
that everyone has access to the latest 
medical research and expertise. But 
we aim to be more than just an open-
access alternative to established general 
medical journals. We are determined 
to make PLoS Medicine the best medical 
journal in the world by providing 
outstanding original research and new 
ideas; thought-provoking, educational, 
and imaginative features for readers; 
and the fastest, fairest, and most 
rigorous peer review for authors. 
As an open-access journal, we see 
our audience differently than do the 
conventional medical journals: our 
audience is composed of medical 
researchers, physicians, and other 
health-care providers, patients and 
their advocates, students, and the 
public around the world. It will be a 
great challenge to create a journal that 
will serve such a diverse audience—we 
welcome this challenge. We will make 
it possible for the results of advanced 
research on infectious diseases to 
guide treatment in remote clinics 
thousands of miles away. We will make 
the results of a clinical trial of a new 
drug accessible and understandable 
both to doctors who might prescribe it 
and to people who might start taking it. 
We will make research on rare diseases 
accessible to general practitioners and 
patients so that they can work together 
to recognize and treat them. 
Whereas some would argue 
that medical journals should not 
be accessible to patients because 
patients are unable to use the 
information effectively, we believe it 
is our responsibility as publishers and 
members of the medical community 
not only to give patients access, but 
to provide them with tools to use the 
medical literature wisely. Medical 
research is a partnership between 
medical scientists and millions 
of voluntary human participants, 
conducted largely with public funds. 
What better way to acknowledge the 
public’s contribution and ensure their 
willingness to sponsor and participate 
in future research than to openly share 
the product of this research with them? 
We hope that you will enjoy reading 
PLoS Medicine and ﬁ  nd it useful and 
provocative. Please share the journal 
with your colleagues, patients, and 
friends. Tell us what you want to see, 
what you like, and what we could do 
better. Give us your ideas for changes 
that will make PLoS Medicine a better 
journal for you and the community. 
Join us in reinventing the medical 
journal.
References
1.  Internet World Stats (2004) Internet usage 
statistics—The big picture: World Internet 
users and population stats. Available: 
http:⁄⁄www.internetworldstats.com/stats.htm. 
Accessed 30 August 2004.
2.  Pew Internet and American Life Project 
(2003) Internet health resources. Available: 
http:⁄⁄www.pewinternet.org/pdfs/pip_health_
report_july_2003.pdf. Accessed 30 August 2004.
3.  The Wellcome Trust (2003) Economic analysis 
of scientiﬁ  c research publishing: A report 
commissioned by the Wellcome Trust, revised 
ed. Available: http:⁄⁄www.wellcome.ac.uk/en/
images/SciResPublishing3_7448.pdf. Accessed 
30 August 2004.
4.  The Wellcome Trust (2004) Scientiﬁ  c 
publishing: A position statement by the 
Wellcome Trust in support of open access 
publishing. Available: http:⁄⁄www.wellcome.
ac.uk/en/1/awtvispolpub.html. Accessed 30 
August 2004.
5.  The Wellcome Trust (2004) Costs and business 
models in scientiﬁ  c research publishing: A 
report commissioned by the Wellcome Trust. 
Available: http:⁄⁄www.wellcome.ac.uk/en/
images/costs_business_7955.pdf. Accessed 30 
August 2004.
6.  The Wellcome Trust (2004) New report 
reveals open access could reduce cost of 
scientiﬁ  c publishing by up to 30 per cent. 
Available: http:⁄⁄www.wellcome.ac.uk/en/1/
awtprerel0404n318.html. Accessed 30 August 
2004.
October 2004  |  Volume 1  |  Issue 1  |  e31
It is our responsibility 
as publishers and 
members of the medical 
community not only to 
give patients access to 
the medical literature, 
but to provide them with 
tools to use it wisely.